Am. Riley et al., A CONFORMATIONALLY RESTRICTED CYCLIC PHOSPHATE ANALOG OF INOSITOL TRISPHOSPHATE - SYNTHESIS AND PHYSICOCHEMICAL PROPERTIES, Journal of organic chemistry, 63(2), 1998, pp. 295-305
The design and total synthesis of DL-6-deoxy-6-(hydroxymethyl)-scyllo-
inositol 1:7-cyclic 2,4-trisphosphate (4), a conformationally restrict
ed cyclic phosphate analogue of the second messenger inositol 1,4,5-tr
isphosphate [Ins(1,4,5)P-3], is described. The protected inosose (p-me
thoxybenzyl)-2,4,6-O-methylidynecyclohexanone (7) was obtained from my
oinositol orthoformate in two steps, and Wittig methylenation and then
hydroboration-oxidation using 9-BBN-H/OH-/H2O2 gave the axial hydroxy
methyl derivative 9. A series of protection/ deprotection steps provid
ed the diol 13, which was converted into two cyclic phosphate esters 1
4a and 14b, epimeric at phosphorus, by reaction with (benzyloxy)bis(N,
N-diisopropylamino)phosphine /1H-tetrazole followed by m-CPBA. Two oth
er hydroxyl groups were then exposed and phosphorylated, and total dep
rotection gave racemic 4. NMR studies confirmed that in 4 the phosphat
e group equivalent to the 4-phosphate of Ins(1,4,5)P-3 is held in the
positive gauche orientation and that the inositol ring maintains a cha
ir conformation from pH 2 to 12. Investigation of the acid-base proper
ties of 4 using potentiometric and P-31 NMR techniques showed that, ov
er the physiological pH range, 4 behaves as a diprotic acid and that t
he ionization of the phosphate group equivalent to the 5-phosphate of
Ins(1,4,5)P-3 is enhanced. In biological assays, 4 appears to behave a
s a weak full agonist at the platelet Ins(1,4,5)P-3 receptor, and the
possible interpretation of this result is discussed.